DELCATH SYSTEMS INC (DCTH) 3.34 +0.44 (+15.17%)
3.34 +0.44 (+15.17%)
US24661P8077 - Common Stock
Fundamental Rating
Overall DCTH gets a fundamental rating of 2 out of 10. We evaluated DCTH against 221 industry peers in the Health Care Equipment & Supplies industry. DCTH has a bad profitability rating. Also its financial health evaluation is rather negative. DCTH shows excellent growth, but is valued quite expensive already.
Profitability
Profitability Rating
DCTH has negative profitability rations, so we won't be analyzing them here.
DCTH has a Return On Assets of -156.79%. This is below the industry average of -19.67%. 96% of the industry peers outperform DCTH.
DCTH's Profit Margin of -757.03% is worse than the rest of the industry. The industry average Profit Margin is -30.04%. 87% of the industry peers have a better Profit Margin.
DCTH has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of DCTH.
VS Industry
ROA (-156.79%) VS Industry: 4% outperformed.
-771.54
117.69
Profit Margin (-757.03%) VS Industry: 13% outperformed.
-142,068.42
1,450.19
Valuation
Valuation Rating
DCTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DCTH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
VS Industry
Growth
Growth Rating
The Revenue has grown by 113.94% in the past year. This is a very strong growth!
DCTH shows quite a strong growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 12.30% yearly.
The Revenue is expected to grow by 167.95% on average over the next 5 years. This is a very strong growth
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The earnings per share for DCTH have decreased by -7.06% in the last year.
DCTH is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 7.58% yearly.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | N/A | N/A | -7.06% | -2.51% | 18.5% | 20.39% | 7.58% |
| Revenue | 12.3% | 1.4% | 113.94% | 42.86% | 174.22% | 173.52% | 167.95% |
Health
Health Rating
A Current Ratio of 1.28 indicates that DCTH should not have too much problems paying its short term obligations.
A Quick Ratio of 1.15 indicates that DCTH should not have too much problems paying its short term obligations.
Compared to an average industry Current Ratio of 3.69, DCTH is worse placed to pay its short term obligations than its industry peers. 90% of its industry peers have a better Current Ratio.
When comparing the Quick Ratio of DCTH to the average industry Current Ratio of 2.91, DCTH is less able to pay its short term obligations than its industry peers. 86% of its industry peers have a better Quick Ratio.
The Debt to Equity ratio of DCTH is negative (-1.85). This means it has negative shareholder equity as the company's liabilities exceed its assets. This could be considered a sign of high risk.
DCTH has an Altman-Z score of -34.64. This is a bad value and indicates that DCTH is not financially healthy and even has some risk of bankruptcy.
When comparing the Altman-Z score of DCTH to the average industry Altman-Z score of 1.89, DCTH is less financially healthy than its industry peers. 99% of its industry peers have a better Altman-Z score.
The Piotroski-F score of DCTH is 3.00. This is a low score and indicates issues in the health and profitability of DCTH.
VS Industry
Quick Ratio (1.15) VS Industry: 14% outperformed.
0.06
31.22
Current Ratio (1.28) VS Industry: 10% outperformed.
0.13
31.22
Altman-Z (-34.64) VS Industry: 1% outperformed.
-105.06
72.93
Dividend
Dividend Rating
No dividends for DCTH!.
DELCATH SYSTEMS INC3.34
NASDAQ:DCTH (12/8/2022, 3:30:01 PM)+0.44 (+15.17%)
| GICS Sector | Health Care | ||
| GICS IndustryGroup | Health Care Equipment & Services | ||
| GICS Industry | Health Care Equipment & Supplies | ||
| Earnings (Last) | 11-08 2022-11-08/bmo | Earnings (Next) | 03-23 2023-03-23 |
| Ins Owners | 6.68% | Inst Owners | 14.16% |
| Market Cap | 28.72M | Analysts | 85.45 |
| PE | N/A | Fwd PE | N/A |
| PEG (NY) | N/A | PEG (5Y) | N/A |
| P/S | 6.86 | P/B | N/A |
| EV/EBITDA | -1.11 | ||
| Dividend Yield | N/A | Dividend Growth | N/A |
| DP | 0% | Ex-Date | N/A |
| EPS 1Y | -7.06% | EPS 3Y | N/A |
| EPS 5Y | N/A | EPS growth Q2Q | 2.13% |
| EPS Next Y | -2.51% | EPS Next 2Y | 18.5% |
| EPS Next 3Y | 20.39% | EPS Next 5Y | 7.58% |
| Revenue growth 1Y | 113.94% | Revenue growth 3Y | 1.4% |
| Revenue growth 5Y | 12.3% | Revenue growth Q2Q | 73.56% |
| Revenue Next Year | 42.86% | Revenue Next 2Y | 174.22% |
| Revenue Next 3Y | 173.52% | Revenue Next 5Y | 167.95% |
| Current Ratio | 1.28 | Quick Ratio | 1.15 |
| Altman-Z | -34.64 | F-Score | 3 |
| Debt/Equity | -1.85 | WACC | 9.86% |
| ROIC/WACC | N/A | ||
| ROA | -156.79% | ROE | N/A |
| ROICexgc | N/A | ROIC | N/A |
| PM | -757.03% | OM | -691.93% |
| Asset Turnover | 0.21 | ||
Fundamental Stock Screener Links
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Growth Stock Screener
Find more growth stocks the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA